Moderna Inc. buy Ellritze
Start price
22.01.22
/
70%
€137.00
Target price
22.01.23
€165.00
Performance (%)
4.37%
End price
06.02.22
€142.98
Summary
This prediction ended on 06.02.22 with a price of €142.98. The BUY prediction by Ellritze finished with a performance of 4.37%. Ellritze has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Moderna Inc. | -6.877% | -6.877% | -44.690% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
According to Ellritze what are the pros and cons of Moderna Inc. for the foreseeable future?
Pros
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Cons
Higher risks for its business
Below average Marketposition
Comments by Ellritze for this prediction
In the thread Moderna Inc. diskutieren
Buy mit Kursziel 165,0
In the thread Trading Moderna Inc.
Buy beendet
Stopped prediction by Ellritze for Moderna Inc.
Moderna Inc.
Start price
Target price
Perf. (%)
€158.84
04.04.22
04.04.22
€178.00
04.04.23
04.04.23
-12.49%
19.04.22
19.04.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Moderna Inc.
Start price
Target price
Perf. (%)
€162.42
21.03.22
21.03.22
€180.00
21.03.23
21.03.23
-2.20%
04.04.22
04.04.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Moderna Inc.
Start price
Target price
Perf. (%)
€139.80
21.01.22
21.01.22
€160.00
21.01.23
21.01.23
-2.00%
22.01.22
22.01.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Moderna Inc.
Start price
Target price
Perf. (%)
€224.75
25.12.21
25.12.21
€260.00
25.12.22
25.12.22
-14.41%
06.01.22
06.01.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Moderna Inc.
Start price
Target price
Perf. (%)
€232.00
12.12.21
12.12.21
€260.00
12.12.22
12.12.22
-3.13%
25.12.21
25.12.21
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Moderna Inc.
Start price
Target price
Perf. (%)
€274.00
01.12.21
01.12.21
€260.00
01.12.22
01.12.22
-15.33%
12.12.21
12.12.21
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business